RESEARCH TITLE: " STUDY OF FACTORS INFLUENCING MORBIDITY AND ROLE OF DEXAMETHASONE IN LABORATORY-CONFIRMED DENGUE PATIENTS: A SINGLE CENTRE RETROSPECTIVE ANALYSIS"
Main Article Content
Keywords
Abstract
Background: Dengue is a significant global health concern, particularly in tropical and subtropical regions. Understanding the factors influencing morbidity and the potential benefits of treatments like Dexamethasone is crucial for improving patient outcomes. This study focuses on the clinical and laboratory parameters that predict ICU admission and evaluates the role of Dexamethasone in managing severe Dengue cases.
Objectives: The study aims to determine the incidence of Dengue patients requiring critical care and extended hospital stays, identify clinical and laboratory risk factors associated with ICU admission, and investigate the effect of steroids, specifically Dexamethasone, in reducing hospital stay and complications in laboratory-confirmed Dengue patients.
Methodology: This observational, retrospective study used medical records of laboratory-confirmed Dengue patients at Vedant Hospital, Pimpri, Pune. Data collected included demographic information, clinical presentation, laboratory parameters, severity indicators, steroid usage, total length of stay, and ICU duration.
Results: Among 200 patients, 58% were male and 42% female, with a majority (94%) residing in urban areas. ICU admissions showed no significant associations with gender, address, or age. Decreased appetite (69% ICU vs. 39.4% non-ICU, p<0.0001) and chest pain (3.4% ICU vs. 0% non-ICU, p=0.026) were more common in ICU patients, while myalgia was more frequent in non-ICU patients (31% vs. 6.9%, p<0.0001).
ICU patients had lower platelet counts (61,310 ± 72,229 vs. 127,355 ± 87,736, p<0.0001) and higher bilirubin (0.88 ± 0.67 vs. 0.73 ± 0.30, p=0.036) and ALT levels (130.21 ± 129.03 vs. 92.98 ± 90.93, p=0.022). Neutrophil counts were higher in ICU patients (63.34 ± 15.71 vs. 57.13 ± 20.57, p=0.04). Hemoglobin levels were higher in ICU patients (14.21 ± 1.87 vs. 13.54 ± 1.70, p=0.015). Oxygen supplementation was required by 6.9% of ICU patients (p<0.0001).
Steroid use was more prevalent in ICU patients (93.1% vs. 84.5%). SDP transfusions were more common in ICU patients (72.4% vs. 1.4%, p<0.0001).
Patients treated with Dexamethasone (N=174) had longer illness durations (5.29 ± 1.41 days vs. 4.54 ± 1.10 days, p=0.01) and lower platelet counts (98.7 ± 86.4 x 10^3 vs. 171.8 ± 77.5 x 10^3, p<0.001), indicating Dexamethasone use in severe cases.
Conclusion: Significant clinical and laboratory differences exist between ICU and non-ICU Dengue patients. Dexamethasone was used in more severe cases, suggesting its potential role in managing severe Dengue symptoms and complications. Further research is needed to determine the benefits of steroid use in Dengue treatment
References
2. Gupta A, Rijhwani P, Pahadia MR, Kalia A, Choudhary S, Bansal DP, et al. Prevalence of Dengue Serotypes and Its Correlation With the Laboratory Profile at a Tertiary Care Hospital in Northwestern India. Cureus. 2021 May;13(5):e15029.
3. Bhavsar A, Tam CC, Garg S, Jammy GR, Taurel A-F, Chong S-N, et al. Estimated dengue force of infection and burden of primary infections among Indian children. BMC Public Health. 2019 Aug;19(1):1116.
4. Pang J, Leo Y-S, Lye DC. Critical care for dengue in adult patients: an overview of current knowledge and future challenges. Curr Opin Crit Care. 2016 Oct;22(5):485– 90.
5. Ang LW, Thein T-L, Ng Y, Boudville IC, Chia PY, Lee VJM, et al. A 15-year review of dengue hospitalizations in Singapore: Reducing admissions without adverse consequences, 2003 to 2017. PLoS Negl Trop Dis. 2019 May;13(5):e0007389.
6. Rajender A, C. D, K. K, Chaudhri R, R. G, C. P. Dengue: multicentre clinical profile of patients admitted in intensive care unit. Int J Res Med Sci. 2016 Jan 1;855–8.
7. Leo Y-S, Thein TL, Fisher DA, Low JG, Oh HM, Narayanan RL, et al. Confirmed adult dengue deaths in Singapore: 5-year multi-center retrospective study [Internet]. Vol. 11, BMC infectious diseases. Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore. yee_sin_leo@ttsh.com.sg; 2011. p. 123. Available from: http://europepmc.org/abstract/MED/21569427
8. Gupta A, Juneja D, Singh O, Garg SK, Arora V, Deepak D. Clinical Profile, Intensive Care Unit Course, and Outcome of Patients Admitted in Intensive Care Unit with Chikungunya. Indian J Crit care Med peer-reviewed, Off Publ Indian Soc Crit Care Med. 2018 Jan;22(1):5–9.
9. Amâncio FF, Heringer TP, de Oliveira C da CHB, Fassy LB, de Carvalho FB, Oliveira DP, et al. Clinical Profiles and Factors Associated with Death in Adults with Dengue Admitted to Intensive Care Units, Minas Gerais, Brazil. PLoS One. 2015;10(6):e0129046.
10. Pang J, Thein T-L, Leo Y-S, Lye DC. Early clinical and laboratory risk factors of
intensive care unit requirement during 2004-2008 dengue epidemics in Singapore: a matched case-control study. BMC Infect Dis. 2014 Dec;14:649.
11. Pang J, Salim A, Lee VJ, Hibberd ML, Chia KS, Leo YS, et al. Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study. PLoS Negl Trop Dis. 2012;6(5):e1641.
12. Futrakul P, Poshyachinda M, Mitrakul C, Kwakpetoon S, Unchumchoke P, Teranaparin C, et al. Hemodynamic response to high-dose methyl prednisolone and mannitol in severe dengue-shock patients unresponsive to fluid replacement. Southeast Asian J Trop Med Public Health. 1987 Sep;18(3):373–9.
13. Tassniyom S, Vasanawathana S, Chirawatkul A, Rojanasuphot S. Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. Pediatrics. 1993 Jul;92(1):111–5.
14. Sumarmo, Talogo W, Asrin A, Isnuhandojo B, Sahudi A. Failure of hydrocortisone to affect outcome in dengue shock syndrome. Pediatrics. 1982 Jan;69(1):45–9.
15. Finsterer J, Kongchan K. Severe, persisting, steroid-responsive Dengue myositis. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2006 Apr;35(4):426–8.
16. Myo‐Khin, Soe-Thein, Thein‐Thein‐Myint, Than-Nu-Swe, Tin-Tin-Saw, Muya-Than. Serum cortisol levels in children with dengue haemorrhagic fever. J Trop Pediatr [Internet]. 1995;41 5:295–7. Available from: https://api.semanticscholar.org/CorpusID:205337166
17. Tam DTH, Ngoc T V, Tien NTH, Kieu NTT, Thuy TTT, Thanh LTC, et al. Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial. Clin Infect Dis an Off Publ Infect Dis Soc Am. 2012 Nov;55(9):1216–24.
18. Rigau-Perez JG, Laufer MK. Dengue-related deaths in Puerto Rico, 1992-1996: diagnosis and clinical alarm signals. Clin Infect Dis. 2006;42(9):1241–1246.
19. Guzman MG, Alvarez M, Rodriguez R, Rosario D, Vazquez S, Vald s L, Cabrera MV, Kouri G. Fatal dengue hemorrhagic fever in Cuba, 1997. Int J Infect Dis. 1999;3(3):130–135
20. Ong A, Sandar M, Chen MI, Sin LY. Fatal dengue hemorrhagic fever in adults during a dengue epidemic in Singapore. Int J Infect Dis. 2007;11(3):263–267.
21. Marois I, Forfait C, Inizan C, Klement-Frutos E, Valiame A, Aubert D, et al . Development of a bedside score to predict dengue severity. BMC Infect Dis. 2021 May 24;21(1):470.
22. Annane D, Bellissant E, Bollaert PE, Briegel J, Confalonieri M, De Gaudio R, Keh D, Kupfer Y, Oppert M, Meduri GU. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA. 2009 Jun 10;301(22):2362-75
23. Kularatne SAM, Walathara C, Mahindawansa SI, Wijesinghe S, Pathirage MMK, Kumarasiri PVR, et al. Efficacy of low dose dexamethasone in severe thrombocytopenia caused by dengue fever: a placebo controlled study. Postgraduate Medical Journal 2009;85:525‐9.
24. Zhang F, Kramer CV. Corticosteroids for dengue infection. Cochrane Database Syst Rev. 2014 Jul 1;2014(7):CD003488
25. Dengue Clinical Case Management E-learning Centers for Disease Control and Prevention. Steroids in Dengue Fever [Internet]. Year [cited 2024 Januray 20]. Available from: https://www.cdc.gov/dengue/training/cme/ccm/Steroids_F.pdf
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr.Abhishek Karmalkar
Consultant Vedant Multispecialty Hospital,Pimpri,Pune
Deepak Bagde
Deepak Bagde, Head Operations, Clinithink Services, Pune.